C

CASI Pharmaceuticals
D

CASI

5.20000
USD
-0.07
(-1.33%)
Market Closed
Volume
1,639
EPS
-3
Div Yield
-
P/E
-2
Market Cap
80,397,496
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMP
    0
    (0%)
    0.000000 USD
    A
    AEZS
    0
    (0%)
    0.000000 USD
    C
    CRMD
    -0.660
    (-6.00%)
    10.340 USD
    C
    CYTK
    -4.440
    (-8.12%)
    50.270 USD
    E
    EVLO
    0
    (0%)
    0.000000 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    K
    KALA
    0.01000
    (0.15%)
    6.87000 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    More
News

Title: CASI Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.